phrykt

TEVA Pharmaceutical Industries (TEVA) revenue: $17.3B

TEVA Pharmaceutical Industries reported $17.3B of revenue for the year ended Dec 31, 2025, up 4.3% from $16.5B a year earlier.

From TEVA Pharmaceutical Industries's filings with the SEC · Read the filing · TEVA stock page

TEVA Pharmaceutical Industries revenue by year

$15.9B2021$14.9B2022$15.8B2023$16.5B2024$17.3B2025

#269 of 3,623 US companies by revenue · See the full ranking

Year endedRevenueChange
Dec 31, 2025$17.3B+4%
Dec 31, 2024$16.5B+4%
Dec 31, 2023$15.8B+6%
Dec 31, 2022$14.9B-6%
Dec 31, 2021$15.9B–

Revenue of similar companies

Companies in the same industry as TEVA Pharmaceutical Industries, by SEC industry code, with the closest revenue. Each name opens the same page for that company.

CompanyRevenue, latest yearYear ended
Abbott Laboratories$44.3BDec 31, 2025
TEVA Pharmaceutical Industries$17.3BDec 31, 2025
Regeneron Pharmaceuticals$14.3BDec 31, 2025
Viatris$14.3BDec 31, 2025
Vertex Pharmaceuticals Inc / Ma$12BDec 31, 2025
Bausch Health Companies$10.3BDec 31, 2025
Zoetis$9.5BDec 31, 2025

Questions and answers

What is TEVA Pharmaceutical Industries's revenue?

TEVA Pharmaceutical Industries reported $17.3B of revenue for the year ended Dec 31, 2025, up 4.3% from $16.5B a year earlier.

Numbers as reported in TEVA Pharmaceutical Industries's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology